Clinical Trial Update: Study Evaluating Renal Cell Carcinoma Risk Factors

View source ↗

Summary

Pfizer-sponsored clinical trial evaluating risk factors for renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell | Status: COMPLETED